Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to HER2-positive Breast Cancer
Related studies linked through entity extraction aliases.
A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Fasting on Newly Diagnosed Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Patients With Brain Metastases From HER2-positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025
- Status
- TERMINATED
- Phase
- PHASE1
Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent HER2-Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
CharactHer. ICORG 12-09, V3
- Status
- TERMINATED
- Phase
- N/A
PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer
- Status
- TERMINATED
- Phase
- NA
Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE1
Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1